With the analysis among 1,461 patents, we discovered top 291 key players by total patent application. OncoTherapy Science, Inc., Eli Lilly & Co., Novartis AG are dominant in this area. They take 17.45% of the total patent filing.
Kanagawa-ken, Japan
Patent: 111
Indiana, United States
Patent: 73
Basel-Stadt, Switzerland
Patent: 71
Washington, United States
Patent: 51
Massachusetts, United States
Patent: 43
Cancer Prevention & Cure Ltd
Tokyo-to, Japan
Patent: 29
Neuchâtel, Switzerland
Patent: 22
Massachusetts, United States
Patent: 21
With the analysis among 18 patents, we discovered top 3 start-ups by total patent application.
California, United States
Patent: 4
With the analysis among related 153 patents applied in the last 5 years. We discover 96 most active companies in this area. The fast-growing Glaxosmithkline Intellectual Property Development Ltd., The Francis Crick Institute Ltd., Novartis AG take 15.03% of patent filing during this period.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 11
Basel-Stadt, Switzerland
Patent: 6
Neuchâtel, Switzerland
Patent: 4
Shanghai Shi, China
Patent: 3
With the analysis among related 153 patents in last 5 years, we discover 62 new entrants. The Francis Crick Institute Ltd., Ervaxx Ltd., Tosoh Corp. are the most active new entrants in this area.
Shanghai Shi, China
Patent: 3
Tianjin Shi, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Liaoning Sheng, China
Patent: 2
With the analysis among 440 patents, we discovered top 102 universities and scientific research institutions by total patent application. University of Southern California, Duke University, University of Tokyo are dominant in this area. They take 11.59% of the total patent filing.
California, United States
Patent: 11
North Carolina, United States
Patent: 11
Tokyo-to, Japan
Patent: 10
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 8
Vlaams-Brabant, Belgium
Patent: 8
Ohio, United States
Patent: 7
Ohio, United States
Patent: 6